Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
Combining Portfolio Asset Classes
By Dr. David Edward Marcinko; MBA, CMP™
Publisher-in-Chief
Combining the disparate information of a physician’s investment portfolio, into a workable asset allocation strategy, is as much art as it is science; perhaps even more so.
Most doctors, investors or endowment fund managers will use a combination of quantitative and qualitative analyses to develop their allocations.
The quantitative portion of the analyses generally uses a variety of statistical techniques to develop a top-down approach to the general allocation.
After developing a general sense of their desired range of returns, many doctors and investors will then use one of several “optimizer” techniques to assist in constructing such an allocation.
Commonly used optimization techniques include Mean Portfolio Variance Optimization (MPVO) – discussed elsewhere in the Executive Post – and Monte Carlo Simulation (MCS).
Monte Carlo Simulation [MCS]
Named after Monte Carlo, Monaco, which is famous for its games of chance, MCS is a technique that randomly changes a portfolio variable over numerous iterations in order to simulate an outcome and develop a probability forecast of successfully achieving an outcome.
In institutional and individual portfolio management, MCS is used to demonstrate the probability of “success” as defined by achieving the endowment’s asset growth and payout goals.
In other words, MCS can provide the physician, investor or endowment fund manager with a comfort level that a given payout policy and asset allocation success will not deplete the real value of the endowment.
Beware the Divorce from Judgment
Nevertheless, the problem with many quantitative tools is the divorce of judgment from their use. And, although useful, both MPVO and MCS have limitations that make it so they should not supplant physician insight, investor experience, or portfolio manager judgment.
For example, MPVO generates an efficient frontier by relying on several inputs, like expected rate-of-return, expected volatility and correlation coefficients. These variables are commonly input using historical measures as proxies for estimated future performance; which is not ascertainable.
Assessment
These facts alone may present a variety of problems:
-
First, the MPVO will generally assume that returns are normally distributed and that this distribution is stationary. As such, asset classes with high historical returns are assumed to have high future returns; and this may or may not be true.
-
Second, an MPVO optimizer is not generally time sensitive. In other words, the optimizer may ignore current environmental conditions that would cause a secular shift in a given asset class returns.
-
Finally, an MPVO optimizer may be subject to selection bias for certain asset classes. For example, private equity firms that fail, as was prominently noted in 2007 and 2008, will no longer report results and will be eliminated from the index used to provide the optimizer’s historical data-base.
Conclusion
And so, do you consider MPVO and Monte Carlo Simulation [MCS] when constructing your own investment portfolio? Why or why not?
Speaker: If you need a moderator or a speaker for an upcoming event, Dr. David Edward Marcinko; MBA – Editor and Publisher-in-Chief – is available for speaking engagements. Contact him at: MarcinkoAdvisors@msn.com
Your thoughts are appreciated.
BUSINESS, FINANCE AND INSURANCE TEXTS FOR DOCTORS:
THANK YOU
Share this:
Filed under: Portfolio Management |
Leave a Reply